Utility of Interferon-γ Release Assay Results to Monitor Anti-Tubercular Treatment in Adults and Children

Clinical Therapeutics

Volumn 34, Issue 5, 2012, Pages 1041-1048

  Chiappini, Elena ^a   Fossi, Francesca ^a   Bonsignori, Francesca ^a   Sollai, Sara ^a   Galli, Luisa ^a   de Martino, Maurizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; GAMMA INTERFERON; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADULT DISEASE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; CHILDHOOD DISEASE; DISEASE ACTIVITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LONGITUDINAL STUDY; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; ANTITUBERCULAR AGENTS; CHILD; DRUG MONITORING; HUMANS; INTERFERON-GAMMA RELEASE TESTS; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TIME FACTORS; TUBERCULOSIS;

EID: 84860780826     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2012.03.006     Document Type: Review

References (28)

1. Dyrhol-Riise A.M., Gran G., Wentzel-Larsen T., et al. Diagnosis and follow-up of treatment of latent tuberculosis: the utility of the QuantiFERON-TB Gold In-Tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010, 10:57.
2. Herrmann J.L., Belloy M., Porcher R., et al. Temporal dynamics of interferon-gamma responses in children evaluated for tuberculosis. PLoS One 2009, 4:e4130.
3. Connell T.G., Davies M.A., Johannisen C., et al. Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tubercular treatment in HIV-infected children. BMC Infect Dis 2010, 10:138.
4. Nicol M.P., Piennar D., Wood K., et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005, 40:1301-1308.
5. Adetifa I.M., Ota M.O., Walther B., et al. Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PLoS One 2010, 5:e12502.
6. Lee S.H., Lew W.J., Kim H.K., et al. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak. Respir Med 2010, 104:448-453.
7. Ribeiro S., Dooley K., Hackman J., et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis 2009, 9:23.
8. Kobashi Y., Sugiu T., Ohue Y., et al. Long term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med 2008, 47:1957-1961.
9. Bosshard V., Roux-Lombard P., Perneger T., et al. Do results of the T-SPOT.TB interferon-gamma release assay change after treatment of tuberculosis?. Respir Med 2009, 103:30-34.
10. Franken W.P., Arend S.M., Thijsen S.F., et al. Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. Int J Tuberc Lung Dis 2008, 12:1286-1294.
11. Goletti D., Parracino M.P., Butera O., et al. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 2007, 8:5.
12. Aiken A.M., Hill P.C., Fox A., et al. Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis 2006, 6:66.
13. Lee S.W., Lee C.T., Yim J.J. Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis 2010, 10:300.
14. Bocchino M., Chairadonna P., Matarese A., et al. Limited usefulness of QuantiFERON-TB Gold In-Tube for monitoring anti-tuberculosis therapy. Respir Med 2010, 104:1551-1556.
15. Nenadic N., Kirin B.K., Letoja I.Z., et al. Serial interferon-g release assay in children with latent tuberculosis infection and children with tuberculosis. Pediatr Pulmonol 2011, 10:1002.
16. Chee C.B., KhinMar K.W., Gan S.H., et al. Tuberculosis treatment effect on T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J 2010, 36:355-361.
17. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000, 283:2008-2012. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.
18. Machingaidze S., Wiysonge C.S., Gonzalez-Angulo Y., et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011, 30:694-700.
19. Diel R., Loddenkemper R., Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis. Chest 2010, 137:952-968.
20. Dheda K., Pooran A., Pai M., et al. Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results. J Infect 2007, 55:169-173.
21. Dominguez J., De Souza-Galvao M., Ruz-Manzano J., et al. T-cell responses to the Mycobacterium tuberculosis-specific antigen in active tuberculosis patients at the beginning, during, and after anti-tuberculosis treatment. Diagn Microbiol Infect Dis 2009, 63:4351.
22. Sauzullo I., Mengoni F., Lichtner M., et al. In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. PLoS One 2009, 4:e5187.
23. Hill P.C., Brookes R.H., Fox A., et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 2007, 4:e192.
24. Pai M., Joshi R., Dogra S., et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009, 13:84-92.
25. Carrara S., Vincenti D., Petrosillo N., et al. Use of A T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004, 38:754-756.
26. Pavić I., Topić R.Z., Raos M., et al. Interferon-γ release assay for the diagnosis of latent tuberculosis in children younger than 5 years of age. Pediatr Infect Dis J 2011, 30:866-870.
27. Bergamini B.M., Losi M., Vaienti F., et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 2009, 123:e419-e424.
28. Ferrand R.A., Bothamley G.H., Whelan A., Dockrell H.M. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 2005, 9:1034-1039.